Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;69(2):312-9.
doi: 10.1002/ana.22244. Epub 2010 Nov 12.

Eating and hypothalamus changes in behavioral-variant frontotemporal dementia

Affiliations
Free PMC article

Eating and hypothalamus changes in behavioral-variant frontotemporal dementia

Olivier Piguet et al. Ann Neurol. 2011 Feb.
Free PMC article

Abstract

Objective: Behavioral-variant frontotemporal dementia (bvFTD) is a progressive neurodegenerative brain disorder, clinically characterized by changes in cognition, personality, and behavior. Marked disturbances in eating behavior, such as overeating and preference for sweet foods, are also commonly reported. The hypothalamus plays a critical role in feeding regulation, yet the relation between pathology in this region and eating behavior in FTD is unknown. This study aimed to address this issue using 2 complementary approaches.

Methods: First, 18 early stage bvFTD patients and 16 healthy controls underwent high-resolution structural magnetic resonance imaging and assessment of eating behavior. Hypothalamic volumes were traced manually on coronal images. Second, postmortem analyses of 12 bvFTD cases and 6 matched controls were performed. Fixed hypothalamic tissue sections were stained for a cell marker and for peptides regulating feeding behaviors using immunohistochemistry. Stereological estimates of the hypothalamic volume and the number of neurons and glia were performed.

Results: Significant atrophy of the hypothalamus in bvFTD was present in both analyses. Patients with high feeding disturbance exhibited significant atrophy of the posterior hypothalamus. Neuronal loss, which was observed only in bvFTD cases with Tar DNA protein-43 deposition, was also predominant posteriorly. In contrast, orexin (hypocretin), neuropeptide Y, cocaine- and amphetamine-regulating transcript, and vasopressin-containing neurons that regulate appetite were spared in posterior nuclei known to participate in feeding regulation.

Interpretation: Degeneration and consequent dysregulation within the hypothalamus relates to significant feeding disturbance in bvFTD. These findings provide a basis for the development of therapeutic models.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Diagrammatic representation of the appetite-stimulating (green) and appetite-suppressing (red) pathways between the periphery and the hypothalamus, and of their connections within hypothalamic nuclei. PVN = paraventricular nucleus; LHA = lateral hypothalamic area; DMN = dorsomedial nucleus; DHA = dorsal hypothalamic area; VMN = ventromedial nucleus; NPY = neuropeptide Y; CART = cocaine- and amphetamine-regulated transcript; ARC = arcuate nucleus.
FIGURE 2
FIGURE 2
Volumetric changes in the hypothalamus of patients with behavioral-variant frontotemporal dementia (bvFTD) compared to healthy controls. Volumes are standardized to a percentage of the mean hypothalamic volume of the healthy control group (the gray band reflecting the standard deviation). (A) In vivo anterior and posterior hypothalamic volumes in bvFTD corrected for head size. Significant atrophy in the posterior hypothalamus atrophy is observed in bvFTD at presentation. (B) In vivo hypothalamic volumes in bvFTD patients exhibiting high or low feeding disturbance corrected for head size. Greater atrophy of the posterior hypothalamus (white bar, right) is present in bvFTD patients with high feeding disturbances at presentation compared to bvFTD patients with low feeding disturbance and compared with healthy controls. (C) Postmortem absolute anterior and posterior hypothalamic volumes in frontotemporal lobar degeneration (FTLD). Significant posterior hypothalamic atrophy in FTLD is observed. (D) Postmortem absolute hypothalamic volumes in FTLD patients exhibiting different inclusion pathologies. More severe posterior hypothalamic atrophy is observed in the FTLD-TDP group (white bar, right) compared with the FTLD-tau group, and compared with healthy controls. MRI = magnetic resonance imaging; TDP-43 = TAR-DNA–binding protein 43. *Posterior hypothalamus in this group is significantly smaller than that of healthy controls; ** posterior hypothalamus in this group is significantly smaller than those of the other two groups.
FIGURE 3
FIGURE 3
Comparisons of the posterior hypothalamic regions (the dorsomedial [DM] and lateral hypothalamus [LH] nuclei) involved in appetite stimulation between controls and frontotemporal lobar degeneration (FTLD) cases with tau or TAR-DNA–binding protein (TDP) pathology reveals neuronal loss in FTLD-TDP compared to both controls and FTLD-tau (row 1) in Nissl-stained sections (0.5% aqueous cresyl violet [CV] and 0.1% Luxol fast blue [LFB]). Insets illustrate tau (column 2) and TDP-43 (column 3) immunopositive inclusion pathology observed in these regions. Immunoperoxidase staining with cocaine- and amphetamine-regulating transcript (CART, rows 2 and 4) and orexin (rows 3 and 5) reveal no evident differences in the density or morphology of neurons containing these neuropeptides across groups in either the DM (rows 2 and 3) or the LH (rows 4 and 5).
FIGURE 4
FIGURE 4
Comparison of the arcuate nucleus (Arc) between controls and frontotemporal lobar degeneration (FTLD) cases with tau or TAR-DNA–binding protein (TDP) pathology. Nissl staining (0.5% aqueous cresyl violet [CV] and 0.1% Luxol fast blue) reveals no noticeable differences in neuron density in Arc (row 1). Immunoperoxidase staining for cocaine- and amphetamine-regulating transcript (CART, row 2) within appetite-suppressing neurons and neuropeptide Y (NPY, row 3) within appetite-stimulating neurons show no noticeable degeneration of these neurons across groups. Similarly, there were no apparent differences in the staining for vasopressin and CART in the periventricular nucleus (PVN) between the groups.

Similar articles

Cited by

References

    1. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–1621. - PubMed
    1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–1554. - PubMed
    1. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5–22. - PMC - PubMed
    1. Pickering-Brown SM. Progranulin and frontotemporal lobar degeneration. Acta Neuropathol. 2007;114:39–47. - PubMed
    1. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 1992;8:159–168. - PubMed

Publication types

LinkOut - more resources

-